What does Penumbra, Inc. do?

Jun 22 2025 06:28 PM IST
share
Share Via
Penumbra, Inc. is a healthcare company specializing in interventional therapies for neuro and peripheral vascular conditions, with recent net sales of $324 million and a market cap of approximately $9.91 billion. Key financial metrics include a P/E ratio of 84.00 and a return on equity of 9.83%.
Overview:
Penumbra, Inc. is a healthcare company focused on interventional therapies within the Pharmaceuticals & Biotechnology industry, specifically targeting neuro and peripheral vascular medical conditions. Financial Snapshot: - Most recent Net Sales: 324 Million (Quarterly Results - Mar 2025) - Most recent Net Profit: 39 Million (Quarterly Results - Mar 2025) - Market cap: USD 9,911.90 Million (Mid Cap) Key Metrics: - P/E: 84.00 - Dividend Yield: 0.00% - Debt Equity: -0.30 - Return on Equity: 9.83% - Price to Book: 8.17 Contact Details: - Address: 1 Penumbra, ALAMEDA CA : 94502-7676 - Tel: 1 510 9952486 - Website: http://www.penumbrainc.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News